Fair Value Calculator Fair Value Calculator
EN DE

Domesco Medical Import - Export Joint-Stock Corporation (DMC) Fair Value & Analysis

Healthcare · VN · Market cap 2.0T VND

DM Domesco Medical Import - Export Joint-Stock Corporation DMC · VN
Price57,300 VND
Fair Value95,266 VND
Upside+66.3%
Quality60/100
Watch Domesco Medical Import - Export Joint-Stock Corporation for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range 57,493 VND – 121,401 VND

Fair value as of: Jul 16, 2026

From 26 valuation models · updated today

Share price −2.2% over the past month.

Price vs Fair Value (12 months)

64,400 VND 56,600 VND Fair Value 95,266 VND May 2025 Jul 2026

12‑month range 56,600 VND – 64,400 VND · fair‑value band 57,493 VND – 121,401 VND · the 57,300 VND price screens below the 95,266 VND fair value. As of Jul 16, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Domesco Medical Import - Export Joint-Stock Corporation (DMC) currently trades at 57,300 VND, while our model-based Fair Value estimate is 95,266 VND — implying the stock looks roughly 66.3% undervalued today. We read business quality at 60/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, Domesco Medical Import - Export Joint-Stock Corporation generated revenue of 2.1T VND at a net margin of 9.7%. Revenue grew 10.8% year over year. It earns a return on equity of 12.0%. The stock trades on a trailing P/E of 12.0. Fundamentals as of Jul 16, 2026

Our scenario range runs from 57,493 VND (bear case) to 121,401 VND (bull case); at 57,300 VND, the current price sits below that range. The share trades about 13% below its 52-week high and 4% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -53% fair-value upside — at 66%, DMC screens cheaper than that median.

Key figures & financial health

Revenue (TTM) 2.1T VND
Revenue growth (YoY) +10.8%
Net margin 9.7%
Return on equity 12.0%
Free cash flow 125B VND FY2025
P/E ratio 12.0
More key figures
Operating margin 11.2%
EPS (TTM) 4,999 VND
EPS growth (YoY) +12.5%

Figures from reported company fundamentals (EODHD) · as of Jul 16, 2026. TTM = trailing twelve months.

About the company

Domesco Medical Import - Export Joint-Stock Corporation engages in the research and development, manufacturing, marketing, and trading of pharmaceutical materials, functional food, pure drinking water and medical beverages in Vietnam. The company is also involved in the import and export of medicines, medicine materials, food-functional food, medical supplies, and medical equipment. It provides herbal, food, dietary supplement, and anti-epidermic products, as well as synthetic drug products such as, cardiovascular agents; antidiabetics; antibiotics; analgesics and antipyretic drugs; respiratory agents; gastrointestinal drugs; minerals and vitamins; and other synthetic drug products. The company offers its products under the Domesco brand name. The company was founded in 1989 and is headquartered in Cao Lãnh, Vietnam. Domesco Medical Import - Export Joint-Stock Corporation is a subsidiary of Abbott Laboratories(Chile) Holdco SpA.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Domesco Medical Import - Export Joint-Stock Corporation reported revenue of 2.1T VND in FY2025 versus 1.5T VND in FY2021, a compound +8.4%/yr. Reported net income was 198B VND in FY2025, compounding +5.6%/yr from FY2021.

Revenue +8.4%/yr
FY21 1.5T VND
FY22 1.6T VND
FY23 1.7T VND
FY24 1.9T VND
FY25 2.1T VND
Net income +5.6%/yr
FY21 159B VND
FY22 200B VND
FY23 183B VND
FY24 203B VND
FY25 198B VND

Is DMC fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "Domesco Medical Import - Export Joint-Stock Corporation Fair Value". https://www.fairvalue-calculator.com/stock/DMC

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).

Stock Price Fair Value vs Fair Value
Jiangsu Hengrui Pharmaceuticals Co 1276 HK$57.85 HK$29.84 -48%
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,782 ₹915.92 -49%
Zoetis Inc Z1TS34 R$25.93 R$19.70 -24%
Hansoh Pharmaceutical Group 3692 HK$29.32 HK$23.94 -18%
Divi's Laboratories Limited DIVISLAB ₹6,788 ₹2,035 -70%
PharmaEssentia Corporation 6446 934.00 TWD 365.87 TWD -61%
Torrent Pharmaceuticals Limited TORNTPHARM ₹4,464 ₹1,504 -66%
Cipla Limited CIPLA ₹1,377 ₹628.39 -54%
Zydus Lifesciences Limited ZYDUSLIFE ₹1,098 ₹507.31 -54%
Dr. Reddy's Laboratories Limited DRREDDY ₹1,278 ₹595.34 -53%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Domesco Medical Import - Export Joint-Stock Corporation (DMC) undervalued?
As of Jul 16, 2026, our model estimates a fair value of 95,266 VND versus a price of 57,300 VND — about +66% (undervalued). Model-based estimate, not financial advice.
What is the fair value of DMC?
Our model-based fair value for Domesco Medical Import - Export Joint-Stock Corporation is 95,266 VND (as of Jul 16, 2026), built from audited fundamentals. The current price is 57,300 VND.
What is the quality score of DMC?
Domesco Medical Import - Export Joint-Stock Corporation has a Quality Score of 60/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Domesco Medical Import - Export Joint-Stock Corporation (DMC)?
Domesco Medical Import - Export Joint-Stock Corporation reported trailing-twelve-month revenue of about 2.1T VND (latest available figure, as of Jul 16, 2026).
What is the net profit margin of DMC?
The net profit margin of Domesco Medical Import - Export Joint-Stock Corporation is about 9.7%, meaning it keeps roughly 9.7% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

14 days Pro free · no card

Unlock the full Domesco Medical Import - Export Joint-Stock Corporation analysis — and try Pro free

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.